InVita Healthcare Technologies Buys BloodHub
Summary
Led by CEO Michael Pandelakis, BloodHub is a company focused on delivering web enabled blood management applications. Its newest offering, BloodRelay, is a 510(k)-cleared system that automates IRL (Immunohematology Reference Lab) workflows including patient and sample management, testing, and reporting. Led by CEO Todd Collins, InVita provides chain of custody software technologies for complex medical, forensic and community care environments. Its solutions optimize supply chains, tracking, and visibility across blood and plasma operations, the tissue and implant lifecycle, and environments spanning DNA and forensics. InVita’s solutions support increased compliance and cost control, reduced risk, and improved patient and public safety outcomes.